153 related articles for article (PubMed ID: 24452361)
1. Conjugation of vitamin E analog α-TOS to Pt(IV) complexes for dual-targeting anticancer therapy.
Suntharalingam K; Song Y; Lippard SJ
Chem Commun (Camb); 2014 Mar; 50(19):2465-8. PubMed ID: 24452361
[TBL] [Abstract][Full Text] [Related]
2. Nanoemulsion enhances α-tocopherol succinate bioavailability in rats.
Gao Y; Qi X; Zheng Y; Ji H; Wu L; Zheng N; Tang J
Int J Pharm; 2016 Dec; 515(1-2):506-514. PubMed ID: 27746330
[TBL] [Abstract][Full Text] [Related]
3. Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
Gruber J; Staniek K; Krewenka C; Moldzio R; Patel A; Böhmdorfer S; Rosenau T; Gille L
Bioorg Med Chem; 2014 Jan; 22(2):684-91. PubMed ID: 24393721
[TBL] [Abstract][Full Text] [Related]
4. The role of alpha tocopheryl succinate (α-TOS) as a potential anticancer agent.
Angulo-Molina A; Reyes-Leyva J; López-Malo A; Hernández J
Nutr Cancer; 2014; 66(2):167-76. PubMed ID: 24364743
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Mediated Mitochondrial Damage Induces Apoptosis in Cancer.
Mallick A; More P; Syed MM; Basu S
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13218-31. PubMed ID: 27160664
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of α-tocopheryl succinate on cisplatin- and etoposide-induced apoptosis.
Kruspig B; Zhivotovsky B; Gogvadze V
Mitochondrion; 2013 Sep; 13(5):533-8. PubMed ID: 22971517
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and in-vitro antitumor activity of the polyethylene glycol (350 and 1000) succinate derivatives of the tocopherol and tocotrienol isomers of Vitamin E.
Abu-Fayyad A; Nazzal S
Int J Pharm; 2017 Mar; 519(1-2):145-156. PubMed ID: 28093324
[TBL] [Abstract][Full Text] [Related]
8. Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy.
Muhammad N; Wang X; Wang K; Zhu C; Zhu Z; Jiao Y; Guo Z
Dalton Trans; 2016 Aug; 45(33):13169-78. PubMed ID: 27333997
[TBL] [Abstract][Full Text] [Related]
9. Vitamin B₁₂ as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies.
Ruiz-Sánchez P; König C; Ferrari S; Alberto R
J Biol Inorg Chem; 2011 Jan; 16(1):33-44. PubMed ID: 20803225
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Effect of α-Tocopheryl Succinate Delivered by Mitochondria-Targeted Mesoporous Silica Nanoparticles.
Qu Q; Ma X; Zhao Y
ACS Appl Mater Interfaces; 2016 Dec; 8(50):34261-34269. PubMed ID: 27998109
[TBL] [Abstract][Full Text] [Related]
11. Anticancer and antiangiogenic activity of surfactant-free nanoparticles based on self-assembled polymeric derivatives of vitamin E: structure-activity relationship.
Palao-Suay R; Aguilar MR; Parra-Ruiz FJ; Fernández-Gutiérrez M; Parra J; Sánchez-Rodríguez C; Sanz-Fernández R; Rodrigáñez L; Román JS
Biomacromolecules; 2015 May; 16(5):1566-81. PubMed ID: 25848887
[TBL] [Abstract][Full Text] [Related]
12. Bid integrates intrinsic and extrinsic signaling in apoptosis induced by alpha-tocopheryl succinate in human gastric carcinoma cells.
Zhao Y; Li R; Xia W; Neuzil J; Lu Y; Zhang H; Zhao X; Zhang X; Sun C; Wu K
Cancer Lett; 2010 Feb; 288(1):42-9. PubMed ID: 19640637
[TBL] [Abstract][Full Text] [Related]
13. Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications.
Greco E; Basso D; Fadi E; Padoan A; Fogar P; Zambon CF; Navaglia F; Bozzato D; Moz S; Pedrazzoli S; Plebani M
Pancreas; 2010 Jul; 39(5):662-8. PubMed ID: 20562578
[TBL] [Abstract][Full Text] [Related]
14. Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their Derivatives.
Neophytou CM; Constantinou AI
Biomed Res Int; 2015; 2015():584862. PubMed ID: 26137487
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E-based micelles enhance the anticancer activity of doxorubicin.
Danhier F; Kouhé TT; Duhem N; Ucakar B; Staub A; Draoui N; Feron O; Préat V
Int J Pharm; 2014 Dec; 476(1-2):9-15. PubMed ID: 25245548
[TBL] [Abstract][Full Text] [Related]
16. A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.
Wang Z; Xu Z; Zhu G
Angew Chem Int Ed Engl; 2016 Dec; 55(50):15564-15568. PubMed ID: 27736029
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor efficacy of hybrid micelles with mitochondrial targeting and stimuli-responsive drug release behavior.
Chen Z; Zhang Z; Chen M; Xie S; Wang T; Li X
J Mater Chem B; 2019 Mar; 7(9):1415-1426. PubMed ID: 32255012
[TBL] [Abstract][Full Text] [Related]
18. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
[TBL] [Abstract][Full Text] [Related]
19. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
20. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation.
Wang H; Yang X; Zhao C; Wang PG; Wang X
Bioorg Med Chem; 2019 Apr; 27(8):1639-1645. PubMed ID: 30852077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
